PPARGC1A and amyotrophic lateral sclerosis: The aforementioned ability of butyrate to upregulate PGC-1α, combined with the reported deregulation of PGC-1α expression in ALS patients and the emerging role of mitochondria in ALS pathogenesis, suggests that microbiome composition is a major determinant of disease onset and progression [14].